secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0000014272-25-000147
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol Myers Q3 revenue $12.2B (+3% YoY), GAAP EPS $1.08, raises FY revenue guidance to ~$47.5-48B
--------------------------------------------------------------------------------

- Total revenues $12,222M (+3% YoY; +2% ex-FX); Growth Portfolio $6.9B (+18% ex-FX).
- GAAP EPS $1.08 (up 81% YoY); non-GAAP EPS $1.63 (down 9% YoY); both include $(0.20) net impact from Acquired IPRD and licensing.
- FY 2025 revenue guidance raised to ~$47.5B-$48.0B; non-GAAP EPS expected $6.40-$6.60 (includes $(0.80) net Acquired IPRD impact).
- Q3 2024 comparatives: revenue $11,892M, GAAP EPS $0.60, non-GAAP EPS $1.80.
- CEO cites Growth Portfolio momentum, pipeline advancements, and strategic business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/0000014272-25-000147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/bmy-20251030.htm
  HTML page:      https://secwatch.observer/filing/0000014272-25-000147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer